| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.15 | 0.3 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.05 | 0.3 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.3 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.031 | 0.3 |